Addiction Medicine
Original Research
Multimodal Pain Management With Adductor Canal Block Decreases Opioid Consumption Following Total Knee Arthroplasty
A retrospective cohort study found that a multimodal medication regimen for TKAs that included an adductor canal block resulted in significant...
News
Short-acting opioids needed for withdrawal in U.S. hospitals, say experts
The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to...
News
Lithium’s antisuicidal effects questioned
The researchers note that the study did not reach its original recruitment goal.
News
U.S. overdose deaths hit an all-time high
Fentanyl and methamphetamine are contributing to rising numbers of fatalities, federal officials say.
Conference Coverage
Alcohol-related liver disease severity increased during COVID-19 pandemic
Increased alcohol sales and disrupted services may have led to worse clinical outcomes.
Conference Coverage
Warn patients about illicit drugs doctored with fentanyl
Most patients with drug use disorders are testing positive for fentanyl at his center, said Dr. Edwin A. Salsitz, of Mount Sinai Beth Israel.
News
Good news, bad news for buprenorphine in opioid use disorder
The findings “underscore the need to pursue actions that expand access to buprenorphine-based OUD treatment,” said Dr. Beth Han and associates.
Latest News
FDA approves combo pill for severe, acute pain
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.
Opinion
Substance use or substance use disorder: A question of judgment
Should we discharge the intoxicated patient as soon as they are safe to walk out or make every effort possible to find long-term solutions?
News
FDA OKs new high-dose naloxone product for opioid overdose
“The higher intramuscular doses of naloxone in ZIMHI should result in more rapid and higher levels of naloxone in the systemic circulation.”